Trials / Conditions / Malignant Pleural Mesotheliomas
Malignant Pleural Mesotheliomas
3 registered clinical trials studyying Malignant Pleural Mesotheliomas — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma NCT07510815 | Beijing Biotech | Phase 1 / Phase 2 |
| Terminated | Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Block NCT03233724 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM) NCT02603315 | Ain Shams University | — |